nach oben

Erschienen in:

21.04.2021 | Systematic Reviews and Meta-analyses

Management of primary and renal hyperparathyroidism: guidelines from the German Association of Endocrine Surgeons (CAEK)

verfasst von: T. Weber, C. Dotzenrath, H. Dralle, B. Niederle, P. Riss, K. Holzer, J. Kußmann, A. Trupka, T. Negele, R. Kaderli, E. Karakas, F. Weber, N. Rayes, A. Zielke, M. Hermann, C. Wicke, R. Ladurner, C. Vorländer, J. Waldmann, O. Heizmann, S. Wächter, S. Schopf, W. Timmermann, D. K. Bartsch, R. Schmidmaier, M. Luster, K. W. Schmid, M. Ketteler, C. Dierks, P. Schabram, T. Steinmüller, K. Lorenz

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Background and aims

The purpose of this review is to provide updated recommendations for the surgical management of primary (pHPT) and renal (rHPT) hyperparathyroidism, formulating a new guideline of the German Association of Endocrine Surgeons (CAEK).

Methods

Evidence-based recommendations for the diagnosis and therapy of pHPT and rHPT were assessed by a multidisciplinary panel using PubMed for a comprehensive literature search together with a structured consensus dialogue (S2k guideline of the Association of the German Scientific Medical Societies, AWMF).

Results

During the last 20 years, a variety of new preoperative localization procedures, such as sestamibi-SPECT, 4D-CT, and various PET/CT procedures, were established for pHPT. High-resolution imaging, together with intraoperative parathyroid hormone (IOPTH) measurement, enabled focused or minimally invasive surgery to become the most favored surgical technique. Patients with pHPT and nonlocalizing imaging have a higher risk of multiglandular disease. Surgical therapy provides very high cure rates, with a clear relation to the surgeon’s experience in parathyroid procedures. Reoperative parathyroidectomy, children with pHPT or familial forms, and parathyroid carcinoma are addressed and require special surgical expertise. A multidisciplinary team of experienced nephrologists, transplant, and endocrine surgeons should assess the diagnosis and treatment of renal HPT.

Conclusion

Surgery is the only curative treatment for pHPT and should be considered for all patients with pHPT. For rHPT, a more selective approach is required, and parathyroidectomy is indicated only when conservative treatment options fail. In parathyroid carcinoma, the adequacy of local resection influences local disease control.

Nilsson IL (2019) Primary hyperparathyroidism: should surgery be performed on all patients? Current evidence and residual uncertainties. J Intern Med 285:149–164PubMedCrossRef

Chirurgische Therapie des primären Hyperparathyreoidismus. Mitteilungen der Deutschen Gesellschaft für Chirurgie G86, Heft 04/1999

Lundstam K, Heck A, Mollerup C, Godang K, Baranowski M, Pernow Y, Varhaug JE, Hessman O, Rosén T, Nordenström J, Jansson S, Hellström M, Bollerslev J, SIPH Study Group (2015) Effects of parathyroidectomy versus observation on the development of vertebral fractures in mild hyperparathyroidism. J Clin Endocrinol Metab 100:1359–1367PubMedCrossRef

Roman SA, Sosa JA, Pietrzak RH, Snyder PJ, Thomas DC, Udelsman R, Mayes L (2011) The effects of serum calcium and parathyroid hormone changes on psychological and cognitive function in patients undergoing parathyroidectomy for primary hyperparathyroidism. Ann Surg 253:131–137PubMedCrossRef

Espiritu RP, Kearns AE, Vickers KS, Grant C, Ryu E, Wermers RA (2011) Depression in primary hyperparathyroidism: prevalence and benefit of surgery. J Clin Endocrinol Metab 96:E1737–E1745PubMedCrossRef

Weber T, Eberle J, Messelhäuser U, Schiffmann L, Nies C, Schabram J, Zielke A, Holzer K, Rottler E, Henne-Bruns D, Keller M, von Wietersheim J (2013) Parathyroidectomy, elevated depression scores, and suicidal ideation in patients with primary hyperparathyroidism: results of a prospective multicenter study. JAMA Surg 148:109–115PubMedCrossRef

Yu N, Donnan PT, Flynn RW, Murphy MJ, Smith D, Rudman A, Leese GP (2010) Increased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS). Clin Endocrinol (Oxf.) 73:30–34

Yu N, Donnan PT, Leese GP (2011) A record linkage study of outcomes in patients with mild primary hyperparathyroidism: the Parathyroid Epidemiology and Audit Research Study (PEARS). Clin Endocrinol 72:169–176CrossRef

Prommegger R, Wimmer G, Profanter C, Sauper T, Sieb M, Kovacs P, Bale R, Putzer D, Gabriel M, Margreiter R (2009) Virtual neck exploration: a new method for localizing abnormal parathyroid glands. Ann Surg 250:761–765PubMedCrossRef

10.

Cheung K, Wang TS, Farrokhyar F, Roman SA, Sosa JA (2012) A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism. Ann Surg Oncol 19:577–583PubMedCrossRef

11.

Weber T, Maier-Funk C, Ohlhauser D, Hillenbrand A, Cammerer G, Barth TF et al (2013) Accurate preoperative localization of parathyroid adenomas with C-11 methionine PET/CT. Ann Surg 257:124–128CrossRef

12.

Beheshti M, Hehenwarter L, Paymani Z, Rendl G, Imamovic L, Rettenbacher R, Tsybrovskyy O, Langsteger W, Pirich C (2018) 18F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with 99mTC-MIBI or 99mTC-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients. Eur J Nucl Med Imaging 45:1762–1771CrossRef

13.

Rajaei MH, Bentz AM, Schneider DF, Sippel RS, Chen H, Oltman SC (2015) Justified follow-up: a final intraoperative parathyroid hormone (ioPTH) over 40 pg/mL is associated with an increased risk of persistence and recurrence in primary hyperparathyroidism. Ann Surg Oncol 22:454–459PubMedCrossRef

14.

Kazaure HS, Thomas S, Scheri RP, Stang MT, Roman SA, Sosa JA (2019) The devil is in the details: assessing treatment and outcomes of 6,795 patients undergoing remedial parathyroidectomy in the Collaborative Endocrine Surgery Quality Improvement Program. Surgery 165:242–249PubMedCrossRef

15.

Westerdahl J, Bergenfelz A (2007) Unilateral versus bilateral neck exploration for primary hyperparathyroidism: five-year follow-up of a randomized controlled trial. Ann Surg 246:976–980PubMedCrossRef

16.

Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh Q-Y, Doherty GM, Herrera MF, Pasieka JL, Perrier ND, Silverberg SJ, Solórzano CC, Sturgeon C, Tublin ME, Udelsman R, Carty SE (2016) The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surgery 151:959–968PubMedCrossRef

17.

KDIGO (2017) Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD) (2017). Kidney Int Suppl 7:1–59CrossRef

18.

Boehm BO, Rosinger S, Belyi D, Dietrich JW (2011) The parathyroid as a target for radiation damage. N Engl J Med 365:676–678PubMedCrossRef

19.

Lehmann SW, Lee J (2013) Lithium-associated hypercalcemia and hyperparathyroidism in the elderly: what do we know? J Affect Disord 146:151–157PubMedCrossRef

20.

Suh JM, Cronan JJ, Monchik JM (2008) Primary hyperparathyroidism: Is there an increased prevalence of renal stone disease? AJR Am J Roentgenol 191:908–911PubMedCrossRef

21.

Tay YD, Liu M, Bandeira L, Bucovsky M, Lee JA, Silverberg SJ, Walker MD (2018) Occult urolithiasis I asymptomatic primary hyperparathyroidism. Endocr Res 43:106–115PubMedPubMedCentralCrossRef

22.

Reid LJ, Muthukrishnan B, Patel D, Seckl JR, Gibb FW (2019) Predictors of nephrolithiasis, osteoporosis, and mortality in primary hyperparathyroidism. J Clin Endocrinol Metab 104:3692–3700PubMedCrossRef

23.

Castellano E, Attanasio R, Boriano A, Pellegrino M, Garino F, Gianotti L, Borretta G (2017) Sex difference in the clinical presentation of primary hyperparathyroidism: influence of menopausal status. J Clin Endocrinol Metab 102:4148–4152PubMedCrossRef

24.

Rigg J, Gilbertson E, Barrett HL, Britten FL, Lust K (2019) Primary hyperparathyroidism in pregnancy: maternofetal outcomes in a quaternary referral obstetric hospital, 2000 through 2005. J Clin Endocrinol Metab 104:721–729PubMedCrossRef

25.

Yang J, Dong MJ, Chen F (2019) A rare lethal case of severe acute necrotisizing pancreatitis due to a parathyroid adenoma in a third-trimester pregnant women. BMC Endocr Disord 19:82PubMedPubMedCentralCrossRef

26.

Mollerup CL, Verstergaard P, Frokjaer VG, Mosekilde L, Christiansen P, Blichert-Toft M (2002) Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow-up study. BMJ 325:807PubMedPubMedCentralCrossRef

27.

VanderWalde LH, Lui IL, Haigh PI (2009) Effect of bone mineral density and parathyroidectomy on fracture risk in primary hyperparathyroidism. World J Surg 33:406–411PubMedCrossRef

28.

Kearns AE, Espiritu RP, Vickers Douglass K, Thapa P, Wermers RA (2019) Clinical characteristics and depression score response after parathyroidectomy in primary hyperparathyroidism. Clin Endocrinol 91:464–470CrossRef

29.

Bannani S, Christou N, Guérin C, Hamy A, Sebag F, Mathonnet M, Guillot P, Caillard C, Blanchard C, Mirallié E (2018) Effect of parathyroidectomy on quality of life and non-specific symptoms in normocalcemic primary hyperparathyroidism. Br J Surg 105:223–229PubMedCrossRef

30.

Wannamethee SG, Welsh P, Papacosta O, Lennon L, Whincup PH, Sattar N (2014) Elevated parathyroid hormone, but not vitamin D deficiency, is associated with increased risk of heart failure in older men with and without cardiovascular disease. Circ Heart Fail 7:732–739PubMedCrossRef

31.

McMahon DJ, Carrelli A, Plameri N, Zahng C, DiTullo M, Silverberg SJ, Waker MD (2015) Effect of parathyroidectomy upon left ventricular mass in primary hyperparathyroidism: a meta-analysis. J Clin Endocrinol Metab 100:4399–4407PubMedPubMedCentralCrossRef

32.

Bergenfelz AO, Hellman P, Harrison B, Sitges-Serra A, Dralle H (2009) Positional statement of the European Society of Endocrine Surgeons (ESES) on modern techniques in pHPT surgery. Langenbecks Arch Surg 394:761–764PubMedCrossRef

33.

Dy BM, Richards ML, Vazquez BJ, Thompson GB, Farley DR, Grant CS (2012) Primary hyperparathyroidism and negative Tc99 sestamibi imaging: to operate or not? Ann Surg Oncol 394:851–860

34.

Bergenfelz AO, Jansson SK, Wallin GK, Martensson HG, Rasmussen L, Eriksson HL, Reihnér EI (2009) Impact of modern techniques on short-term outcome after surgery for primary hyperparathyroidism: a multicenter study comprising 2,708 patients. Langenbecks Arch Surg 394:851–860PubMedCrossRef

35.

Thier M, Daudi S, Bergenfelz A, Almquist M (2018) Predictors of multiglandular disease in primary hyperparathyroidism. Langenbecks Arch Surg 403:103–109PubMedPubMedCentralCrossRef

36.

Elaraj DM, Sippel RS, Lindsay S, Sansano I, Duh QY, Clark OH, Kebebew E (2010) Are additional localization studies and referral indicated for patients with primary hyperparathyroidism who have negative sestamibi scan results? Arch Surg 145:578–581PubMedCrossRef

37.

Huber GF, Hüllner M, Schmid C, Brunner A, Sah B, Vetter D, Kaufmann PA, von Schulthess GK (2018) Benefit of 18F-fluorocholidine PET imaging in parathyroid surgery. Eur J Radiol 28:2700–2707CrossRef

38.

Hessman O, Stalberg P, Sundin A, Garske U, Rudberg C, Eriksson L-G, Hellman P, Akerstrom G (2008) High success rate of parathyroid reoperation may be achieved with improved localization diagnosis. World J Surg 32:774–781PubMedCrossRef

39.

Thanseer N, Bhadada SK, Sood A, Mittal BR, Behera A, Gorla AKR, Kalathoorakathu RR, Singh P, Dahiya D, Saikia UN, Rao SD (2017) Comparative effectiveness of ultrasonography, 99mTc-sestamibi, and 18F-fluorocholine PET/CT in detecting parathyroid adenomas in patients with primary hyperparathyroidism. Clin Nucl Med 42:e491–e497PubMedCrossRef

40.

Reidel MA, Schilling T, Graf S, Hinz U, Nawroth P, Büchler MW, Weber T (2006) Localization of hyperfunctioning parathyroid glands by selective venous sampling in reoperation for primary or secondary hyperparathyroidism. Surgery 140:907–913PubMedCrossRef

41.

Ito F, Sippel R, Lederman J, Chen H (2007) The utility of intraoperative bilateral internal jugular venous sampling with rapid parathyroid hormone testing. Ann Surg 245:959–963PubMedPubMedCentralCrossRef

42.

Starker LF, Bjorklund P, Theoharis C, Long WD 3rd, Carling T, Udelsman R (2011) Clinical and histopathological characteristics of hyperparathyroidism-induced hypercalcemic crisis. World J Surg 35:331–335PubMedCrossRef

43.

Uruno T, Masaki C, Suzuki A, Ohkuwa K, Shibuya H, Kitagawa W, Nagahama M, Sugino K, Ito K (2015) Antimicrobial prophylaxis for the prevention of surgical site infection after thyroid and parathyroid surgery: a prospective randomized trial. World J Surg 39:1282–1287PubMedCrossRef

44.

Riss P, Krall C, Scheuba C, Bieglmayer C, Niederle B (2013) Risk factors for “PTH spikes” during surgery for primary hyperparathyroidism. Langenbecks Arch Surg 398:881–886PubMedCrossRef

45.

Meyer SK, Zorn M, Frank-Raue K, Büchler MW, Nawroth P, Weber T (2009) Clinical impact of two different intraoperative parathyroid hormone assays in primary and renal hyperparathyroidism. Eur J Endocrinol 160:275–281PubMedCrossRef

46.

Miller BS, England BG, Nehs M, Burney RE, Doherty GM, Gauger PG (2006) Interpretation of intraoperative parathyroid hormone monitoring in patients with baseline parathyroid hormone levels of < 100 pg/mL. Surgery 140:883–889PubMedCrossRef

47.

Udelsman R, Lin Z, Donovan P (2011) The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism. Ann Surg 253:585–591PubMedCrossRef

48.

Karakas E, Schneider R, Rothmund M, Bartsch DK, Schlosser K (2014) Initial surgery for benign primary hyperparathyroidism: an analysis of 1,300 patients in a teaching hospital. World J Surg 38:2011–2018PubMedCrossRef

49.

Yabuta T, Tsushima Y, Masuoka H, Tomoda C, Fukushima M, Kihara M, Inoue H, Higashiyama T, Takamura Y, Ito Y, Kobayashi K, Miya A, Miyauchi A (2011) Ultrasononic features of intrathyroidal parathyroid adenoma causing primary hyperparathyroidism. Endocr J 58:989–994PubMedCrossRef

50.

Mazeh H, Kouniavsky G, Schneider DF, Makris KI, Sippel RS, Dackiw APB et al (2012) Intrathyroidal parathyroid glands: small, but mighty (a Napoleon phenomenon). Surgery 152:1192–1200CrossRef

51.

James BC, Kaplan EL, Grogan RH, Angelos P (2015) What´s in a name? Providing clarity in the definition of minimally invasive parathyroidectomy. World J Surg 39:975–980PubMedCrossRef

52.

Grant CS, Thompson G, Farley D, van Heerden J (2005) Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo clinic experience. Arch Surg 140:472–478PubMedCrossRef

53.

Lew JI, Rivera M, Irvin GL 3rd, Solorzano CC (2010) Operative failure in the era of focused parathyroidectomy: a contemporary series of 845 patients. Arch Surg 145:628–633PubMedCrossRef

54.

Venkat R, Kouniavsky G, Tufano RP, Schneider EB, Dackiw AP, Zeiger M (2012) Long-term outcome in patients with primary hyperparathyroidism who underwent minimally invasive parathyroidectomy. World J Surg 36:55–60PubMedCrossRef

55.

Miccoli P, Berti P, Materazzi G, Massi M, Picone A, Minuto MN (2004) Results of video-assisted parathyroidectomy: single institution’s six-year experience. World J Surg 28:1216–1218PubMedCrossRef

56.

Sasanakietkul T, Jitpratoom P, Anuwong A (2017) Transoral endoscopic parathyroidectomy vestibular approach: a novel scarless parathyroid surgery. Surg Endoc 31:3755–3763CrossRef

57.

Karakas E, Anuwong A, Ketwong K, Kounnamas A, Schopf S, Klein G (2018) Transoral thyroid and parathyroid surgery: implementation and evaluation of the transoral endoscopic technique via the vestibular approach (TOETVA). Chirurg 89:537–544PubMedCrossRef

58.

Hurtado-Lopez LM, Gutiérrez-Román SH, Basurto-Kuba E, Luna-Ortiz K (2019) Endoscopic transoral parathyroidectomy: initial experience. Head Neck 41:3334–3337PubMedCrossRef

59.

Landry CS, Grubbs EG, Morris GS, Turner NS, Holsinger FC, Lee JE, Perrier ND (2011) Robot assisted transaxillary surgery (RATS) for the removal of thyroid and parathyroid glands. Surgery 149:549–555PubMedCrossRef

60.

He Q, Zhu J, Zhuang D, Fan Z (2015) Robotic total parathyroidectomy by the axillo-bilateral-breast approach for secondary hyperparathyroidism: a feasibility study. J Laparoendosc Adv Surg Tech 25:311–313CrossRef

61.

VanSlyke S, Van Den Heede K, Magamadov K, Brusselaers N, Vermeersch H (2019) Robotic-assisted parathyroidectomy through lateral cervical approach: first results in Belgium. Acta Chir Belg 22:1–6

62.

Riss P, Kammer M, Selberherr A, Scheuba C, Niederle B (2015) Morbidity associated with concomitant thyroid surgery in patients with primary hyperparathyroidism. Ann Surg Oncol 22:2707–2713PubMedCrossRef

63.

Kiernan CM, Schlegel C, Kavalukas S, Isom C, Peters MF, Solozano CC (2016) Does concomitant thyroidectomy increase risks of parathyroidectomy? J Surg Res 203:34–39PubMedCrossRef

64.

Musholt TJ, Bockisch A, Clerici T, Dotzenrath C, Dralle H, Goretzki PE et al (2018) Aktualisierung der S2k-Leitlinie: operative Therapie benigner Schiddrüsenerkrankungen. Chirurg 89:699–709PubMedCrossRef

65.

Kaderli RM, Riss P, Geroldinger A, Selberherr A, Scheuba C, Niederle B (2018) Primary hyperparathyroidism: dynamic postoperative metabolic changes. Clin Endocrinol 88:129–138CrossRef

66.

Bergenfelz A, Lindblom P, Tibblin S, Westerdahl J (2002) Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial. Ann Surg 236:543–551PubMedPubMedCentralCrossRef

67.

Kaderli RM, Riss P, Dunkler D, Pietschmann P, Selberherr A, Scheuba C, Niederle B (2018) The impact of vitamin D status on hungry bone syndrome after surgery for primary hyperparathyroidism. Eur J Endocrinol 178:1–9PubMedCrossRef

68.

Witteveen JE, van Thiel S, Romijn JA, Hamdy NAT (2013) Hungry bone syndrome: Still a challenge in the postoperative management of primary hyperparathyroidism: a systematic review of the literature. Eur J Endocrinol 168:45–53CrossRef

69.

Hermann M (2010) Primärer Hyperparathyreoidismus: postoperative, normokalzämische Hyperparathyrinämie nach kurativer Parathyreoidektomie. Chirurg 81:447–453PubMedCrossRef

70.

Lou I, Balantine C, Clarkson S, Schneider DF, Sippel RS, Chen H (2017) How long should we follow patients after apparently curative parathyroidectomy? Surgery 161:54–61PubMedCrossRef

71.

Prescott JD, Udelsman R (2009) Remedial operation for primary hyperparathyroidism. World J Surg 33:2324–2334PubMedCrossRef

72.

Karakas E, Müller HH, Schlosshauer T, Rothmund M, Bartsch DK (2013) Reoperations for primary hyperparathyroidism-improvement of outcome over two decades. Langenbecks Arch Surg 398:99–106PubMedCrossRef

73.

Iacobone M, Scerrino G, Palazzo FF (2019) Parathyroid surgery: an evidence-based volume-outcome analysis: European Society of Endocrine Surgeons (ESES) positional statement. Langenbecks Arch Surg 404:919–927PubMedCrossRef

74.

Lou I, Foley D, Odorico SK, Leverson G, Schneider DF, Sippel R, Chen H (2015) How well does renal transplantation cure hyperparathyroidism? Ann Surg 262:653–659PubMedPubMedCentralCrossRef

75.

Cheng SP, Lee JJ, Liu TP, Yang TL, Chen HH, Wu CJ, Liu CL (2014) Parathyroidectomy improves symptomatology and quality of life in patients with secondary hyperparathyroidism. Surgery 155:320–328PubMedCrossRef

76.

Floege J, Kim J, Ireland E, Chazot C, Drueke T, de Francisco A, Kronenberg F, Marcelli D, Passlick-Deetjen J, Schernthaner G, Fouqueray B, Wheeler DC, on behalf of the ARO Investigators (2011) Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant 26:1948–1955PubMedCrossRef

77.

Kim WW, Rhee Y, Kim BS, Kim K, Lee CR, Kang S-W, Lee J, Jeong JJ, Nam KH, Chung WY (2019) Clinical outcomes of parathyroidectomy versus cinacalcet in the clinical management of secondary hyperparathyroidism. Endocr J 66:881–889PubMedCrossRef

78.

Finnerty BM, Chan TW, Jones G, Khader T, Moore M, Gray KD, Beninato T, Watkins AC, Zarnegar R, Fahey TJ III (2019) Parathyroidectomy versus cincalcet in the management of tertiary hyperparathyroidism: surgery improves renal transplant allograft survival. Surgery 165:129–134PubMedCrossRef

79.

National Kidney Foundation (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1–S201CrossRef

80.

Cruzado JM, Moreno P, Torregrosa JV, Taco O, Mast R, Gómez-Vaquero C, Polo C, Revuelta I, Francos J, Torras J, García-Barrasa A, Bestard O, Grinyó JM (2016) A randomized study comparing parathyroidectomy with cinacalcet for treating hypercalcemia in kidney allograft recipients with hyperparathyroidism. J Am Soc Nephrol 27:2487–2494PubMedCrossRef

81.

De la Rosa A, Jimeno J, Membrilla E, Sancho JJ, Pereira JA, Sitges-Serra A (2008) Usefulness of preoperative Tc-mibi parathyroid scintigraphy in secondary hyperparathyroidism. Langenbecks Arch Surg 393:21–24PubMedCrossRef

82.

Lorenz K, Bartsch DK, Sancho JJ, Guigard S, Triponez F (2015) Surgical management of secondary hyperparathyroidism in chronic kidney disease-a consensus report of the European Society of Endocrine Surgeons. Langenbecks Arch Surg 400:907–927PubMedCrossRef

83.

Weber T, Zeier M, Hinz U, Schilling T, Büchler MW (2005) Impact of intraoperative parathyroid hormone levels on surgical results in patients with renal hyperparathyroidism. World J Surg 29:1176–1179PubMedCrossRef

84.

Freriks K, Hermus ARMM, de Sévaux RGL, Bonenkamp HJ, Biert J, Heijer d M et al (2010) Usefulness of intraoperative parathyroid hormone measurement in patients with renal hyperparathyroidism. Head Neck 3:1328–1335CrossRef

85.

Chen J, Jia X, Kong X, Wang Z, Cui M, Xu D (2017) Total parathyroidectomy with autotransplantation versus subtotal parathyroidectomy for renal hyperparathyroidism: a systematic review and meta-analysis. Nephrology 22:388–396PubMedCrossRef

86.

Yuan Q, Liao Y, Zhou R, Liu J, Tang J, Wu G (2019) Subtotal parathyroidectomy versus total parathyroidectomy with autotransplantation for secondary hyperparathyroidism: an updated systematic review and meta-analysis. Langenbecks Arch Surg 404:669–679PubMedCrossRef

87.

Schlosser K, Bartsch DK, Diener MK, Seiler CM, Bruckner T, Nies C, Meyer M, Neudecker J, Goretzki PE, Glockzin G, Konopke R, Rothmund M (2016) Total parathyroidectomy with routine thymectomy and autotransplantation versus total parathyroidectomy alone for secondary hyperparathyroidism: results of a nonconfirmatory multicenter prospective randomized controlled pilot trial. Ann Surg 264:745–753PubMedCrossRef

88.

Schneider R, Waldmann J, Ramaswamy A, Fernández ED, Bartsch DK, Schlosser K (2011) Frequency of ectopic and supernumerary intrathymic parathyroid glands in patients with renal hyperparathyroidism: analysis of 461 patients undergoing initial parathyroidectomy with bilateral cervical thymectomy. World J Surg 35:1260–1265PubMedCrossRef

89.

Schneider R, Ramaswamy A, Slater EP, Bartsch DK, Schlosser K (2012) Cryopreservation of parathyroid tissue after parathyroid surgery for renal hyperparathyroidism: does it really make sense? Surgery 36:2598–2604

90.

Cohen MS, Dilley WG, Wells SA Jr, Moley JF, Doherty GM, Sicard GA, Skinner MA, Norton JA, DeBenedetti MK, Lairmore TC (2005) Long-term functionality of cryopreserved parathyroid autografts: a 13-year prospective analysis. Surgery 138:1033–1040PubMedCrossRef

91.

Goldfarb M, Gondek SS, Lim SM, Farra JC, Nose V, Lew JI (2012) Postoperative hungry bone syndrome in patients with secondary hyperparathyroidism of renal origin. World J Surg 36:1314–1319PubMedCrossRef

92.

Ho LY, Wong PN, Sin HK, Wong YY, Lo KC, Chan SF, Lo MW, Lo KY, Mak SK, Wong AKM (2017) Risk factors and clinical course of hungry bone syndrome after total parathyroidectomy in dialysis patients with secondary hyperparathyroidism. BMC Nephrol 18:12PubMedPubMedCentralCrossRef

93.

Van der Plas WY, Engelsman AF, Özyilmaz A, van der Horst-Schrivers AN, Meijer K, van Dam GM et al (2017) Impact of the introduction of calcimimetics on timing of parathyroidectomy in secondary and tertiary hyperparathyroidism. Ann Surg Oncol 24:15–22PubMedCrossRef

94.

Pattou FN, Pellissier LC, Noel C, Wambergue F, Huglo DG, Proye CA (2000) Supernumerary parathyroid glands: frequency and surgical significance in treatment of renal hyperparathyroidism. World J Surg 24:1330–1334PubMedCrossRef

95.

Dotzenrath C, Cupisti K, Goretzki E, Mondry A, Vossough A, Grabensee B, Röher HD (2003) Operative treatment of renal autonomous hyperparathyroidism: cause of persistent or recurrent disease in 304 patients. Langenbecks Arch Surg 387:348–354PubMedCrossRef

96.

Waldmann J, López CL, Langer P, Rothmund M, Bartsch DK (2010) Surgery for multiple endocrine neoplasia type 1-associated primary hyperparathyroidism. Br J Surg 97:1528–1534PubMedCrossRef

97.

Schreinemakers JMJ, Pieterman CRC, Scholten A, Vriens MR, Valk GD, Rinkes IHMB (2011) The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review. World J Surg 35:1993–2005PubMedCrossRef

98.

Pieterman CRC, van Hulsteijn LT, Heijer d M, van der Luijt RB, Bonenkamp JJ, Hermus ARMM et al (2012) Primary hyperparathyroidism in MEN1 patients: a cohort study with long-term follow-up on preferred surgical procedure and the relation with genotype. Ann Surg 255:1171–1178PubMedCrossRef

99.

Nilubol N, Weinstein LS, Simonds WF, Jensen RT, Marx SJ, Kebebew E (2016) Limited parathyroidectomy in multiple endocrine neoplasia type 1-asscoiated primary hyperparathyroidism: a setup for failure. Ann Surg Oncol 23:416–423PubMedCrossRef

100.

Iacobone M, Carnaille B, Palazzo FF, Vriens M (2015) Hereditary hyperparathyroidism-a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbecks Arch Surg 400:867–886PubMedCrossRef

101.

Marx JM, Lourenco DM (2017) Familial hyperparathyroidism-disorders of growth and secretion in hormones-secretory tissue. Horm Metab Res 49:805–815PubMedCrossRef

102.

Frank-Raue K, Leidig-Bruckner G, Haag C, Schulze E, Lorenz A, Schmitz-Winnenthal H, Raue F (2011) Inactivating calcium-sensing receptor mutations in patients with primary hyperparathyroidism. Clin Endocrinol 75:50–55CrossRef

103.

Rampp RD, Mancilla EE, Adzick NS, Levine MA, Kelz RR, Fraker DL, Iyer P, Lindeman BM, Mejia VA, Chen H, Wachtel H (2020) Single gland, ectopic localization: adenomas are common causes of primary hyperparathyroidism in children and adolescents. World J Surg 44:1518–1525PubMedPubMedCentralCrossRef

104.

Pashtan I, Grogan RH, Kaplan SP, Devon K, Angelos P, Lui D, Kaplan EI (2013) Primary hyperparathyroidism in adolescents: the same but different. Pediatr Surg Int 29:275–279PubMedCrossRef

105.

Langusch CC, Norlen O, Titmuss A, Donoghue K, Holland AJ, Shun A, Delbridge L (2015) Focused image-guided parathyroidectomy in the current management of primary hyperparathyroidism. Arch Dis Child 100:924–927PubMedCrossRef

106.

Nicholson KJ, McCoy KL, Witchel SF, Stang MT, Carty SE, Yip L (2016) Comparative characteristics of primary hyperparathyroidism in pediatric and young adult patients. Surgery 160:1008–1016PubMedCrossRef

107.

Sosa JA, Tuggle CT, Wang TS, Thomas DC, Boudourakis L, Rivkees S, Roman SA (2008) Clinical and economic outcomes of thyroid and parathyroid surgery in children. J Clin Endocrinol Metab 93:3058–3065PubMedCrossRef

108.

Lenschow C, Schrägle S, Kircher S, Lorenz K, Machens A, Dralle H et al (2020) Clinical presentation, treatment and outcome of parathyroid carcinoma: results of the NEKAR retrospective international multicenter study. Ann Surg in press; EMID:b206508b1c669067

109.

Asari EA, Sturgeon C, Winchester DJ, Liu L, Palis B, Perrier ND et al (2015) Parathyroid carcinoma: an update on treatment course and prognostic factors from the National Cancer Data Base (NCDB). Ann Surg Oncol 22:3390–3995

Titel: Management of primary and renal hyperparathyroidism: guidelines from the German Association of Endocrine Surgeons (CAEK)
verfasst von: T. Weber
C. Dotzenrath
H. Dralle
B. Niederle
P. Riss
K. Holzer
J. Kußmann
A. Trupka
T. Negele
R. Kaderli
E. Karakas
F. Weber
N. Rayes
A. Zielke
M. Hermann
C. Wicke
R. Ladurner
C. Vorländer
J. Waldmann
O. Heizmann
S. Wächter
S. Schopf
W. Timmermann
D. K. Bartsch
R. Schmidmaier
M. Luster
K. W. Schmid
M. Ketteler
C. Dierks
P. Schabram
T. Steinmüller
K. Lorenz
Publikationsdatum: 21.04.2021
Verlag: Springer Berlin Heidelberg
Erschienen in: Langenbeck's Archives of Surgery / Ausgabe 3/2021
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI: https://doi.org/10.1007/s00423-021-02173-1

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich

weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Background and aims

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2021

Robotic and laparoscopic liver resection—comparative experiences at a high-volume German academic center

Practical significance of pancreatectomy with lymphadenectomy around the superior mesenteric artery for pancreatic cancer: comparison of prognosis after adjusting for major prognostic factors

Isolated caudate lobectomy using a modified hanging maneuver

Resectional surgery in gallbladder cancer with jaundice—how to improve the outcome?

Severe acute pancreatitis: surgical indications and treatment

Three-dimensional visualization system is one of the factors that improve short-term outcomes after minimally invasive esophagectomy

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Hinter dieser Appendizitis steckte ein Erreger

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Ureterstriktur: Innovative OP-Technik bewährt sich

Update Chirurgie

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

S2e-Leitlinie „Distale Radiusfraktur“

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“